Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours Β· Estimated delivery Aug 25 - Aug 30
We accept Zelle, Venmo, and cryptocurrency (Bitcoin and Litecoin via BTCPay Server)
Ideal for individuals of all age groups grappling with low energy levels, vitamin deficiencies, or those keen on optimizing their overall health, this treatment promises noticeable results within hours to a few days, with effects typically enduring for several weeks
No claims are made or implied regarding cosmetic, dermatological, or therapeutic effects
Mechanism of Action Tirzepatide acts by activating both: GIP receptors GLP-1 receptors This dual incretin activity helps to: Increase glucose-dependent insulin secretion Reduce glucagon secretion during hyperglycemia Delay gastric emptying Increase satiety and reduce caloric intake Promote clinically meaningful weight loss Improve insulin sensitivity indirectly through weight reduction Clinical Benefits When used as prescribed alongside lifestyle modification, MOUNJARO may help: Improve HbA1c levels Lower fasting and post-meal blood glucose Promote substantial body weight reduction Improve insulin sensitivity Reduce appetite and food intake Support long-term glycemic control Improve several cardiometabolic risk factors through weight reduction Clinical benefits vary among individuals
MECHANISM CATEGORIES SAFETY Side effects GI: nausea, vomiting (titration-dependent) Injection-site reactions Hypoglycemia risk when combined with insulin Known interactions Insulin additive hypoglycemia risk Contraindications History of MTC or MEN2 (theoretical class effect) REGULATORY STATUS FDA Not yet FDA-approved as of 2026-05
US$ 23.17
US$ 24.05
US$ 22.92
US$ 22.97
